Dr. Sharron Gargosky (PhD Biochemist) brings to the team a global executional and operational background for clinical development and strategy that spans more than 25 years. She has personally overseen Regulatory, CMC, Non-clinical, Clinical, Early Commercialization, and Medical Affairs in program across more than 15 countries. This work has spanned across therapeutics (IVD, small molecules, biologics, cellular therapies) and numerous clinical indications. She has lead programs from early research phase through to successful approvals with the U.S. Orphan Drug and Accelerated Food & Drug Administration approval process.

Previously, she worked in academia as a postdoc at Stanford and as an assistant professor at OHSU with numerous publications, before moving to industry with an initial tenure at Pharmacia, Pfizer running phase 3 clinical trials. She has worked and consulted with role as Head of Clinical Development and Operations, Chief Development Officer, Chief Technology and Operations Officer.